Login / Signup

Editorial: real-life data confirm efficacy of elbasvir/grazoprevir in HCV patients with severe kidney disease.

Maria Grazia RumiV Occhipinti
Published in: Alimentary pharmacology & therapeutics (2019)
Keyphrases
  • hepatitis c virus
  • human immunodeficiency virus
  • electronic health record
  • early onset
  • big data
  • hepatitis c virus infection
  • data analysis
  • drug induced
  • machine learning
  • artificial intelligence
  • deep learning